Anti-Human APP Abeta Recombinant Antibody(Bapineuzumab)

Product Information

Catalog Number	YR1164
Product Name	Anti-Human APP Abeta Recombinant Antibody(Bapineuzumab)
Molecular Name	Bapineuzumab
Alias	Anti-APP Abeta Recombinant Antibody, Research Grade Bapineuzumab
CAS Number	648895-38-9
Target	APP Abeta[Homo sapiens]
Isotype	IgG1
Clonity	Monoclonal
Host	Mouse
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	WB, FuncS, IF, Neut, ELISA, FCM, IP
Buffer	PBS, pH7.5
Background	Bapineuzumab (nicknamed "bapi") is a humanized monoclonal antibody that acts on the nervous system and may have potential therapeutic value for the treatment of Alzheimer's disease and possibly glaucoma. However, in 2012 it failed to produce significant cognitive improvements in patients in two major trials, despite lowering key biomarkers of AD, amyloid brain plaque and hyperphosphorylated tau protein in CSF.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price